While this screen was limited to DHL as the cancer model, as CRISPRa technology becomes more accessible it will be interesting to see whether increased expression of BCL-W will emerge as a survival-promoting factor in other cancer types, or in the face of other treatments. This evidence concerns the gene BCL2L2 and cancer.